(Bloomberg) -- Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Asthika Goonewardene Senior Analyst:Biotech Bloomberg Intelligence Discussing Gilead Sciences Inc. agreed to buy Kite Pharma Inc. for about $11.9 billion, making one of its biggest deals ever to expand beyond its eroding hepatitis C drug franchise.

Trump Meets Xi in Washington as Domestic Woes Grow
35:17

Anthony Scaramucci on Trump, Wall Street and America’s Economic Anger
19:44

Trump Addresses Iran Meeting, AI Worries at United Nations
51:08